Evidence map›Paper›PMID 35879419›Full record

ArticleNature structural & molecular biology2022

Proteasome-dependent truncation of the negative heterochromatin regulator Epe1 mediates antifungal resistance.

Imtiyaz Yaseen, Sharon A White, Sito Torres-Garcia, Christos Spanos, Marcel Lafos, Elisabeth Gaberdiel, Rebecca Yeboah, Meriem El Karoui, Juri Rappsilber, Alison L Pidoux and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. HPathogens (Basel, Switzerland) · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Epigenetic Regulation of Antifungal Drug Resistance.Journal of fungi (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Imtiyaz Yaseen *Wellcome Centre for Cell Biology, School of Biological Sciences, The University of Edinburgh, Edinburgh, UK.
Sharon A White *Wellcome Centre for Cell Biology, School of Biological Sciences, The University of Edinburgh, Edinburgh, UK.
Sito Torres-GarciaWellcome Centre for Cell Biology, School of Biological Sciences, The University of Edinburgh, Edinburgh, UK.
Christos SpanosWellcome Centre for Cell Biology, School of Biological Sciences, The University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-4376-8242
Marcel LafosWellcome Centre for Cell Biology, School of Biological Sciences, The University of Edinburgh, Edinburgh, UK.
Elisabeth GaberdielWellcome Centre for Cell Biology, School of Biological Sciences, The University of Edinburgh, Edinburgh, UK.
Rebecca YeboahWellcome Centre for Cell Biology, School of Biological Sciences, The University of Edinburgh, Edinburgh, UK.
Meriem El KarouiInstitute of Cell Biology, School of Biological Sciences, The University of Edinburgh, Edinburgh, UK.
Juri RappsilberWellcome Centre for Cell Biology, School of Biological Sciences, The University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0001-5999-1310
Alison L PidouxWellcome Centre for Cell Biology, School of Biological Sciences, The University of Edinburgh, Edinburgh, UK.
Robin C AllshireWellcome Centre for Cell Biology, School of Biological Sciences, The University of Edinburgh, Edinburgh, UK. robin.allshire@ed.ac.uk.ORCID http://orcid.org/0000-0002-8005-3625
Wellcome Centre for Cell Biology · GBIndian Institute of Integrative Medicine · INUniversity of Dundee · GBUniversity of Edinburgh · GB

Funding

Wellcome Trust 108504Wellcome Trust 200885Wellcome Trust 200885/Z/16/ZWellcome Trust 203149Wellcome Trust 205008Wellcome Trust 205008/Z/16/ZWellcome Trust 218470Wellcome Trust 224358
6 · The paper itself

Abstract

Epe1 histone demethylase restricts H3K9-methylation-dependent heterochromatin, preventing it from spreading over, and silencing, gene-containing regions in fission yeast. External stress induces an adaptive response allowing heterochromatin island formation that confers resistance on surviving wild-type lineages. Here we investigate the mechanism by which Epe1 is regulated in response to stress. Exposure to caffeine or antifungals results in Epe1 ubiquitylation and proteasome-dependent removal of the N-terminal 150 residues from Epe1, generating truncated Epe1 (tEpe1) which accumulates in the cytoplasm. Constitutive tEpe1 expression increases H3K9 methylation over several chromosomal regions, reducing expression of underlying genes and enhancing resistance. Reciprocally, constitutive non-cleavable Epe1 expression decreases resistance. tEpe1-mediated resistance requires a functional JmjC demethylase domain. Moreover, caffeine-induced Epe1-to-tEpe1 cleavage is dependent on an intact cell integrity MAP kinase stress signaling pathway, mutations in which alter resistance. Thus, environmental changes elicit a mechanism that curtails the function of this key epigenetic modifier, allowing heterochromatin to reprogram gene expression, thereby bestowing resistance to some cells within a population. H3K9me-heterochromatin components are conserved in human and crop-plant fungal pathogens for which a limited number of antifungals exist. Our findings reveal how transient heterochromatin-dependent antifungal resistant epimutations develop and thus inform on how they might be countered.

Indexed as

SchizosaccharomycesSchizosaccharomyces pombe ProteinsAntifungal AgentsCaffeineCytoplasmHeterochromatinHumansNuclear ProteinsProteasome Endopeptidase ComplexAntifungal AgentsCaffeineepe1 protein, S pombeHeterochromatinNuclear ProteinsProteasome Endopeptidase ComplexSchizosaccharomyces pombe Proteins

Identifiers

PMID35879419
PMCPMC7613290
OpenAlexW4287510142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.